Ravi Ramesh Jhaveri

  • 1187 Citations
1993 …2019
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

After having served on the faculty at both Duke and UNC, Dr. Jhaveri joined the faculty at Lurie/FSM in October 2018. He currently serves as Associate Division Head for Pediatric Infectious Diseases. Dr. Jhaveri is active in leadership of several infectious diseases society at the national level. He currently serves as a member of the Pediatric Infectious Diseases Society Board of Directors. He is the Vice-Chair of the Infectious Diseases Society of America Leadership Institute working group and is the PIDS liaison to the IDSA Standards, Practice and Guidelines Committee. He is a member of the AASLD-IDSA HCV Guidelines committee where he serves as one of the subgroup chairs on HCV in Children and Pregnant Women.

Dr. Jhaveri has focused on all aspects of Hepatitis C virus infection. In the past, he ran a laboratory dedicated to study the effect of HCV on lipid metabolism in liver cells and viral and host determinants of HCV vertical transmission. He has been very active in studies of HCV in infants and children: epidemiology, natural history and treatment, testing and advocacy. Dr. Jhaveri's other interests include outcomes studies in pediatric infectious diseases, influenza and the live-attenuated influenza vaccine, prevention, treatment and vertical transmission of Hepatitis B, management of febrile infants and physician decision-making.

Dr. Jhaveri's clinical practice is in all aspects of pediatric infectious diseases. His specialty is in management of children with Hepatitis B & C exposure and infection.

Training Experience

1999Residency, University of Chicago Hospitals
2003Fellowship, UCLA Medical Center, Los Angeles, CA

Education/Academic qualification

MD, Mount Sinai School of Medicine

… → 1996

Fingerprint Dive into the research topics where Ravi Ramesh Jhaveri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles
Hepacivirus Medicine & Life Sciences
Virus Diseases Medicine & Life Sciences
Hepatitis C Medicine & Life Sciences
Pediatrics Medicine & Life Sciences
Fever Medicine & Life Sciences
Hepatitis B Medicine & Life Sciences
Hepatitis B virus Medicine & Life Sciences
Antiviral Agents Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1993 2019

Cost Effectiveness of Early Treatment with Direct-Acting Antiviral Therapy in Adolescent Patients with Hepatitis C Virus Infection

Nguyen, J., Barritt, A. S. & Jhaveri, R. R., Apr 1 2019, In : Journal of Pediatrics. 207, p. 90-96 7 p.

Research output: Contribution to journalArticle

Virus Diseases
Hepacivirus
Cost-Benefit Analysis
Antiviral Agents
Quality-Adjusted Life Years

Evaluating Hepatitis B Seroprotection and Revaccination for Children With Inflammatory Bowel Disease

Brenner, E. J., Jhaveri, R. R., Kappelman, M. D. & Gulati, A. S., Aug 20 2019, In : Inflammatory bowel diseases. 25, 9, p. e108

Research output: Contribution to journalArticle

Secondary Immunization
Hepatitis B
Inflammatory Bowel Diseases
Pediatrics
1 Citation (Scopus)

Focusing on the Host Side of Host–Pathogen Interactions

Jhaveri, R., Oct 2019, In : Clinical Therapeutics. 41, 10, p. 1904-1906 3 p.

Research output: Contribution to journalEditorial

Host-Pathogen Interactions

Myths and Misconceptions: Varicella-Zoster Virus Exposure, Infection Risks, Complications, and Treatments

Newman, A. M. & Jhaveri, R. R., Sep 1 2019, In : Clinical Therapeutics. 41, 9, p. 1816-1822 7 p.

Research output: Contribution to journalReview article

Human Herpesvirus 3
Virus Diseases
Chickenpox
Herpes Zoster
Vaccination

Reply to McAuley and Close

Jhaveri, R. R. & Kim, A. Y., Jul 18 2019, In : Clinical Infectious Diseases. 69, 3, p. 557-558 2 p.

Research output: Contribution to journalLetter